熟地杞子炖猪脑对AD小鼠学习记忆能力的影响
|
摘要
本研究旨在探讨熟地杞子炖猪脑在对老年性痴呆小鼠学习记忆能力及相关血清、脑组织生化指标的影响。选用4-5月龄清洁级的ICR健康小鼠112只,雌雄各半,按体重随机分为空白组、模型组、西药组(石杉碱甲)、熟地杞子炖猪脑高剂量组、熟地杞子炖猪脑中剂量组、熟地杞子炖猪脑低剂量组和淮山杞子炖猪脑组等七组。除空白组外,其余各组均采用东莨菪碱(SCOP)、Alcl3与D-gal三因素联合诱导,即实验开始的第1天起,每日于16:00以4mL/只Alcl3水溶液的量灌胃,同时按200mL/kg的剂量于腹腔注射D-gal注射液,并于实验开始的第5周起,中午12:00于腹腔注射2mL/kg的氢溴酸东莨菪碱注射液,建立AD模型。从实验开始第2天起,空白组与模型组每日7:30灌胃20mL/kg的蒸馏水,其余各组灌服相同剂量的药食,连续6周后检测各项指标。通过Y型迷宫测试小鼠的学习记忆能力的变化,用化学比色法测定小鼠血清及脑组织内丙二醛(MDA)的含量和脑组织内乙酰胆碱酯酶(AChE)的活力,用黄嘌呤氧化酶法测定小鼠血清及脑组织内超氧化物歧化酶(SOD)的活力,运用全自动生化分析仪测定血清胆碱酯酶(ChE)活力和血清总胆固醇的含量,并用光学显微镜观察小鼠脑海马组织形态结构的变化。
采用SPSS18.0统计软件对数据进行统计分析显示:与模型组相比,空白组和熟地杞子炖猪脑中剂量组小鼠在体重、学习记忆能力和其他生化指标上均达到显著性差异(P<0.01)。西药组在血清ChE活力和脑组织AChE活力上优于其他药食组,熟地杞子炖猪脑中剂量组在体重、学习记忆能力和血清及脑组织内MDA的含量及超氧化物歧化酶(SOD)的活力等方面,效果较好。在光镜下,小鼠海马CA3区的切片图中模型组小鼠变化最为明显,熟地杞子炖猪脑中剂量组与空白组的变化差异性不显著。
根据结果可得出以下结论:东莨菪碱、Alcl3与D-gal三因素联合诱导对4-5月龄的ICR小鼠的AD模型建造是成功的。熟地杞子炖猪脑能改善AD模型小鼠的学习记忆障碍。熟地杞子炖猪脑对AD模型小鼠海马组织病理改变具有改善作用。熟地杞子炖猪脑可增强SOD的活性,减少MDA在体内的含量,从而改善因氧化引起的氧自由基的改变,发挥其抗氧化作用。熟地杞子炖猪脑能抑制AChE或ChE的活性,降低乙酰胆碱的水解速度起到防治AD的作用。
In this paper, the author’the purpose of this research is to discuss the effect of Shudi Gouqi Dun Zhunao to the senile dementia mouse in learning and memory ability and the related blood serum, the brain organization biochemistry target influence. Selects April to May age clean level ICR healthy mouse 112, is half and half female and male, divides into 7 groups according to the body weight : blank group, model group, western medicine group, Shudi Gouqi Dun zhunao high dose group, Shudi Gouqi Dun zhunao middle dose group, Shudi Gouqi Dun zhunao low dose group and Huaishan Qizi Dun Zhunao. All groups except the blank group, uses the scopolamine (SCOP), Alcl3 and the D-gal three factor union induction, namely the 1st day starts 16:00 to fill stomach 4mL/d in the afternoon the Alcl3 peroxide solution only and injects 200mL/kg D-gal, and starts in the 5th week, noon 12:00 injects 2mL/kg the scopolamina hydrobromidum inoculation fluid, establishes the AD model. The 2nd day starts 7:30 to fill stomach 20mL/kg every day in the morning the distilled water, other each group fills the clothing commensurability the medicine food and examines each target after 6 weeks. Through the Y-maze test of learning and memory ability in mice changes in chemical colorimetric determination of serum and brain tissue malondialdehyde (MDA) content and brain tissue acetylcholinesterase (AChE) of energy, with the yellow Determination of purine oxidase superoxide dismutase (SOD) of the activity, using automatic biochemical analyzer determination of serum cholinesterase (ChE) activity and serum total cholesterol levels, and with an optical microscope hippocampus morphology in mice changes.
SPSS18.0 statistical software used for statistical analysis of data and found that Compared with model group, control group and Shudi Gouqi Dun zhunao middle dose groups in body weight, learning and memory abilities, and other biochemical indicators were significant differences ( P <0.01). Western medicine group in serum ChE activity and brain AChE activity than other drugs groups, Shudi Gouqi Dun zhunao middle dose in body weight, learning and memory ability and brain tissue and serum MDA content and superoxide dismutase ( SOD).The viability so that the effect is good. In the light microscope, hippocampal CA3 area of slices in the model group were the most obvious change, Shudi Gouqi Dun zhunao middle dose group and control group did not change significantly.
The following conclusions can be drawn based on the results: scopolamine, Alcl3 with the D-gal induced by three factors, the AD model mice on the ICR to build is a success. Shudi Gouqi Dun zhunao can improve the AD model of porcine brain stew of learning and memory impairment in mice. Shudi Gouqi Dun zhunao AD stew Porcine Model of pathological changes in hippocampus of mice with the improvement. Shudi Gouqi Dun zhunao SOD stew porcine brain activity can be enhanced to reduce the MDA content in the body, thereby improving the oxidation caused by oxygen free radicals due to the change to play its antioxidant activity. Shudi Gouqi Dun zhunao can inhibit AChE or stew porcine brain ChE activity, reduce the rate of hydrolysis of acetylcholine and thus increase its concentration in the patient's body and thus play a role in AD prevention and treatment.
采用SPSS18.0统计软件对数据进行统计分析显示:与模型组相比,空白组和熟地杞子炖猪脑中剂量组小鼠在体重、学习记忆能力和其他生化指标上均达到显著性差异(P<0.01)。西药组在血清ChE活力和脑组织AChE活力上优于其他药食组,熟地杞子炖猪脑中剂量组在体重、学习记忆能力和血清及脑组织内MDA的含量及超氧化物歧化酶(SOD)的活力等方面,效果较好。在光镜下,小鼠海马CA3区的切片图中模型组小鼠变化最为明显,熟地杞子炖猪脑中剂量组与空白组的变化差异性不显著。
根据结果可得出以下结论:东莨菪碱、Alcl3与D-gal三因素联合诱导对4-5月龄的ICR小鼠的AD模型建造是成功的。熟地杞子炖猪脑能改善AD模型小鼠的学习记忆障碍。熟地杞子炖猪脑对AD模型小鼠海马组织病理改变具有改善作用。熟地杞子炖猪脑可增强SOD的活性,减少MDA在体内的含量,从而改善因氧化引起的氧自由基的改变,发挥其抗氧化作用。熟地杞子炖猪脑能抑制AChE或ChE的活性,降低乙酰胆碱的水解速度起到防治AD的作用。
In this paper, the author’the purpose of this research is to discuss the effect of Shudi Gouqi Dun Zhunao to the senile dementia mouse in learning and memory ability and the related blood serum, the brain organization biochemistry target influence. Selects April to May age clean level ICR healthy mouse 112, is half and half female and male, divides into 7 groups according to the body weight : blank group, model group, western medicine group, Shudi Gouqi Dun zhunao high dose group, Shudi Gouqi Dun zhunao middle dose group, Shudi Gouqi Dun zhunao low dose group and Huaishan Qizi Dun Zhunao. All groups except the blank group, uses the scopolamine (SCOP), Alcl3 and the D-gal three factor union induction, namely the 1st day starts 16:00 to fill stomach 4mL/d in the afternoon the Alcl3 peroxide solution only and injects 200mL/kg D-gal, and starts in the 5th week, noon 12:00 injects 2mL/kg the scopolamina hydrobromidum inoculation fluid, establishes the AD model. The 2nd day starts 7:30 to fill stomach 20mL/kg every day in the morning the distilled water, other each group fills the clothing commensurability the medicine food and examines each target after 6 weeks. Through the Y-maze test of learning and memory ability in mice changes in chemical colorimetric determination of serum and brain tissue malondialdehyde (MDA) content and brain tissue acetylcholinesterase (AChE) of energy, with the yellow Determination of purine oxidase superoxide dismutase (SOD) of the activity, using automatic biochemical analyzer determination of serum cholinesterase (ChE) activity and serum total cholesterol levels, and with an optical microscope hippocampus morphology in mice changes.
SPSS18.0 statistical software used for statistical analysis of data and found that Compared with model group, control group and Shudi Gouqi Dun zhunao middle dose groups in body weight, learning and memory abilities, and other biochemical indicators were significant differences ( P <0.01). Western medicine group in serum ChE activity and brain AChE activity than other drugs groups, Shudi Gouqi Dun zhunao middle dose in body weight, learning and memory ability and brain tissue and serum MDA content and superoxide dismutase ( SOD).The viability so that the effect is good. In the light microscope, hippocampal CA3 area of slices in the model group were the most obvious change, Shudi Gouqi Dun zhunao middle dose group and control group did not change significantly.
The following conclusions can be drawn based on the results: scopolamine, Alcl3 with the D-gal induced by three factors, the AD model mice on the ICR to build is a success. Shudi Gouqi Dun zhunao can improve the AD model of porcine brain stew of learning and memory impairment in mice. Shudi Gouqi Dun zhunao AD stew Porcine Model of pathological changes in hippocampus of mice with the improvement. Shudi Gouqi Dun zhunao SOD stew porcine brain activity can be enhanced to reduce the MDA content in the body, thereby improving the oxidation caused by oxygen free radicals due to the change to play its antioxidant activity. Shudi Gouqi Dun zhunao can inhibit AChE or stew porcine brain ChE activity, reduce the rate of hydrolysis of acetylcholine and thus increase its concentration in the patient's body and thus play a role in AD prevention and treatment.
引文
[1]王德生,张守信主编.老年性痴呆[M].北京:人民卫生出版社,2001,133-152,197-198.
[2]Katzman R,Kawas C.Risk faetor for Alzheimer’s disease[J].Neuroscience News,1998,l:27-34.
[3]杨任民.老年性痴呆—系列保健之二[J].临床中老年保健,2001,4(3):203-206
[4]www.bjzx.gov.cn/zxta/dpta/ng/021.htm
[5]闫芳,李淑然,刘津,等.老年期痴呆和老年抑郁症的流行病学调查[J].中华医学杂志,2002,82(15):1025 - 1028.
[6]汤荟冬.老年期痴呆的流行病学研究近况[J].中国实用内科学杂志,2002,22(6):365 - 366.
[7]Bachman,D.L.,P.A.Wolf,etal. Incidence of dementia and probable Alzheimer’s disease in a general population the Framingham Study[J].Neurology,1993,43(3 Pt 1):515-9.
[8]Rocca,W.A.,A.Hofman,etal. Frequency and distribution of Alzheimer’s disease in Europe:a collaborative study of 1980-1990 Prevalence findings[J]. The EURODEM-Prevalence Research Group.Ann Neurol,1991,30(3):381-90.
[9]许二赫,贾建平.Alzheimer病的分子遗传学进展[J].中风与神经疾病杂志,2002,19(1):59-61.
[10]贾建平,张津,徐敏等.载脂蛋白E基因多态性与散发性阿尔茨海默病的关系[J].中华老年医学杂志,2002,21(4):248-250.
[11]杨小清.老年性痴呆症的流行病学特征及预防[J].职业与健康,2008,24(13):1317-1318.
[12]Akiyama H,Barger S,Barnum S, etal.Inflammation and Alzheimer’s disease[J]. Neurobiology of Aging,2000,21(3):383-421.
[13]Sastre M,Klockgether T,Heneka MT. Contribution of inflammatory Processes to Alzheimer’s disease: molecular mechanisms[J].International Journal of Development Neuroscience,2006,24(2-3):167-176.
[14]Ladurner G,Hiff LD,Lechner H.Clinical factors associated with dementia in ischaemic stroke [J]. Journal of neurology,neurosurgery and psychiatry,1982,45(2):97-101.
[15]AZAD NA,AL BUGAMI M ,LOY-ENGLISH I. Gender Differences in Dementia Risk Factors[J]. Gend Med (S1550 - 8579 ),2007,4(2) :120-129.
[16]Sawada H,Ibi M,Kihara T, etal.Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons [J].The FASEBJ Journal,2000,14(9):1202-1214.
[17]王荫华.阿尔茨海默病的危险因素[J].中华神经科杂志,2003,36(6):477-478.
[18]汤哲,孟琛.瑞士老年医学与老年痴呆研究现状[J].中华老年医学杂志,1999,18(3):191.
[19]Hardy J, Selkoe DJ.The amyloid hypothesis of Alzheimer’s disease: Progress and Problems on the road to therapeutics [J].Science,2002,297(5580):353-356.
[20] Shirotain K, Tsubuki S, IwataN et al. Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapide and efficiently among thiorphan and phosphoramidon sensitive endopeptidases[J].Biol Chem,2001.276 (24):21895-21901.
[21]PiccardiM, CongiuD, Squassina A et al. Alzheimer’s disease: case-control association study of 1polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample1 [J].Am JMed GenetB Neuropsychiatr Genet, 2007, 144 (7):895-899.
[22]Coyle JT,Price DL,DeLong MR. Alzheimer’s disease: a disorder of cortical cholinergic innervation[J].Science,1983,219(4589):1184-1190.
[23] Matsui T, Ingelsson M, Fukumoto H et al. Expression of APP pathway mRNAs and proteins in Alzheimer’s disease1[J].Brain Res, 2007, 1161: 116-123.
[24]Mann D,PickeringcBrowns,Takerchi A,Iwatsubo T. Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer’s disease[J].American Journal of Pathology,2001,158(6):2165.
[25]Mariani E, SeripaD, Ingegni T et al1 Interaction of CTSD and A2M polymorphisms in the risk forAlzheimer’s disease1[J].Neurol Sci,2006,247 (2):187-191.
[26]Lee MS,Kao SC,Lemere CA,etal.APP processing is regulated by cytoplasmic phosphorylation [J]. Cell Biol,2003,163(1):83-95.
[27]Selkoe DJ. Alzheimer’s disease is a synaptic failure[J].Science,2002,298(5594):781-791.
[28] Liu Y, Liu F, Iqbal K et al. Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease[J]. FEB SL ett,2008, 582(2): 359-364.
[29]McGeer PL, McGeer EG..Autotoxicity and Alzheimer disease[J].Arch Neurol,200,57 (6):789 -790.
[30]Aisen PS. The inflammatory hypothesis of Alzheimer disease: dead or alive? [J].Alzheimer Dis Assoc Disord,2008,22(1):4-5.
[31]吴正治,唐春艳,卢汉平.天泰Ⅱ号对实验性老年痴呆益智作用及机理探讨[J].中药新药与临床药理,1999,10(1):32.
[32]Leigh PN, etal. New aspects of the pathology of neurodegrenerative disorders as revealed by ubiquitin antiboeies[J]. Acta NeuroPathol,1989,79:61-72.
[33]丁新生.老年性痴呆的病理、发病机制及其诊断研究[J].中国临床康复,2004,8(19):3174-3176.
[34]Ogomoto K,etal.Re-examination of granulovacuolar degeneration[J].Acta Neuropatho l,1991,12:821-9256.
[35]Terry RD,etal.Some morphometric aspects of the brain in senile dementia of the Alzheimer type[J]. Ann Neurol,1991,10:182-194.
[36]官志忠阿尔茨海默病的病理学及生物膜结构与受体改变机制[J].中华病理学杂志,2003,32(1):425-426.
[37]SpencerCM,Noble S,etal.A reviews of its use in Alzheimer’s disease[J].Drugs-Aging,1998, 13(5):391-411.
[39]Giacobini E. Long-term stabilizing effect of cholinesterase inhibitors in the therapy of Alzheimer’s disease [J].Journal of Neural Transmission Supplemen,2002,(62):181-187.
[38]Rogers SL, Doody R.E2020 produced both clinical global and cognitive test Improvement in patient with mild to moderately sever Alzheimer’s disease: results of a 30-weeks phaseⅢtrial. Neurology,1996,46:217.
[40]钟志耕,梁可珍.石杉碱甲治疗血管性痴29例临床观察[J].海南医学院学报,2004(10) :25.
[41]Frederick B, Satlin A, Wald LL, etal.Brain proton magnetic resonance spectroseopy in Alzheimer’s disease:changes after treatment with xanomeline[J].American Journal of Geriatric Psychiatry,2002,10(l):81-88.
[42]Ishige K, Schubert D, Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms[J].Free Radical Biology and Medicine,2001,30(4):433-466.
[43]Tuszynski MH. Intraparenchymal NGF infusions rescue degenerating cholinergic neurons[J].Cell Transplant,2000,9(5):629-636.
[44]肖飞,罗焕敏.靶向β-和γ-分泌酶治疗阿尔茨海默病的研究进展[J].国外医学,药学分册,2002,29(5):272-278.
[45]Wong GT, Manfra D, Poulet FM, etal. Chronic treatment with the gamma-secretase inhibitorLY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation[J].Journal of Biological Chemistry,2004,279(13):12876-12882.
[46]Andersona JJ, Holtza G, Baskin PP, etal. Reductions in beta-amyloid concentrations in vivo by the gamma-secretas inhibitors BMS-289948andBMS-299897[J].Biochemical Pharmacolo- g,2005,69:689-698.
[47] Grundman M,Delaney P. Antioxidant strategic for Alzheimer’s disease[J].AM.J.Med,2000, 109(7):57-585.
[48] Bard F, Cannon C, Barbour R, etal. Peripherally administered antibodies against amyloid beta peptide enter the central nervous system and reduce Pathology in a mouse model of Alzheimer disease[J].Nature Medicine,2000,6(8):916-919.
[49]胡章,马润娣.药物防治阿尔茨默病研究[J].实用老年医学,2000,14(5):262-264.
[50]Breitner J C, Gau A ,Welsh K A. Inverse association of anti-inflammatory treatments and Alzheimer’s disease:initial results of a cot win control study[J].Neurology,1994,44 (2 ):227.
[51]McGeer PL, McGeer EG.NSAIDs and Alzheimer disease: epidemiological,animal model and clinical studies[J].Neurobiology of Aging,2007,28(5):639-647.
[52]HendersonVW,Paganini2Hill A,Emanuel C K. Estrogen replacement therapy in older women: comparisons between Alzheimer’s disease cases and non-demented control subjects[J].Arch Neurol,1994,51(9) :816.
[53]Baker LD, Sambamurti K, Craft S, et al. 17 beta-estuarial reduces plasma A beta 40 for HRT naive postmenopausal women with Alzheimer disease: a preliminary study[J].Am J Geriatr Psychiatry,2003,11(2):239-244.
[54]高之旭,徐一峰.阿尔采夫病的药物治疗评价[J].中国新药与临床杂志,2000,l9(l):46-48.
[55]卜海涛.中华医学会第三届全国老年期痴呆和抑郁症学术会议纪要[J].中华神经科杂,2004,37(2):102-105.
[56]张映梅.老年痴呆症虚实论治[J].云南中医中药杂志, 2000,21: 36-37.
[57]张新风.补肾填精汤治疗老年性痴呆30例临床观察[J].江西中医药,2005,36(12):23.
[58]腾晶.补肾化痰祛瘀法治疗老年期痴呆机理探讨[J].河南中医,2003,23(7):5-6.
[59]欧阳真理.老年痴呆的病因病机探讨与治疗[J].中华实用中西医杂志,2005,18(13):212.
[60]赵文研,陈荣.从脾论治老年性痴呆症[J].中医药学刊,2005, 23(9):1666.
[61]朱振铎.疏肝解郁、滋肾养心法治疗老年性痴呆34例临床研究[J].山东中医药大学学报,1998,22(5):346-349.
[62]郑丽,翟李娟.辨证分型治疗老年痴呆症30例疗效观察[J].河南中医学院学报,2004,19(4):113.
[63]魏翠柏,田金洲,贾建平.老年痴呆中医病因病机理论的认识与思考[J].中华中医药杂志,2005,20(8):496-497.
[64]董洪涛,金渊光.老年性痴呆痰蒙神窍病因病机探析[J].中国传统医学杂志,2002,20(6):755-756.
[65]宋颖民.痰瘀同治法治疗老年性痴呆体会[J].河北中医,1998,20(4):218-311.
[66]孙明杰,于友华.清热解毒中药防治老年性痴呆症之理论探讨[J].中国中医基础医学杂志,2003, 9(2): 17
[67]张晋,刘荣,董健.名老中医治疗老年性痴呆经验评述[J].中医药信息, 2001, 18(3): 1-2
[68]郑现堂.益精活血通窍法治疗老年性痴呆[J].中原医刊, 2001,28(9): 60-61
[69]李鹏英.心、肾、肝在老年性痴呆发病中的作用[J].长春中医学院学报, 2000, 16(1): 7-8
[70]浦斌红,何建成.浅谈老年性痴呆模型的发病机理及其中医药治疗[J].光明中医,2002, 17(98): 18-19
[71]周念兴.老年性痴呆从胆论治的临床探讨[J].北京中医,1998, (1): 14
[72]魏录翠,胡国恒,张强等.从肺论治老年性痴呆理论探讨[J].江西中医学院学报,2008, 20(5): 16-17
[73]李雅根.浅析从痰瘀互结论治老年性痴呆[J].江西中医药,2002, 33(2): 17
[74]张觉人.呆从痰治[J].上海中医药杂志, 1995, 29(3): 20
[75]赵伟康.调心方对杏仁核注Aβ大鼠记忆行为和胆碱能系统作用的研究[J].现代康复,2001,5(5):48-50.
[76]赵伟康.调理心肾中药对大鼠痴呆模型的胆碱能和肾上腺素能神经系统的影响[J].中国中西医结合杂志,1993,13(特集):20-23.
[77]林长兴.调补心肾改善老年性痴呆智力的临床研究[J].上海中医药杂志,1995,(9):8-10.
[78]原敬二朗.痴呆症和东洋医学[J].日本医事新报,1991,46:3514-3516.
[79]许哲,邵金莺,刘干中.左归丸的一些药理作用[J].中药药理与临床,1990,6(4):6-8.
[80]王昌俊.益智灵为主治疗老年痴呆[J].中国医药学报,1993,8:33-34.
[81]王昌俊.益智灵的益智健脑作用的研究[J].中成药,1993,15(6):28-29.
[82]杨军,魏守建,高丹屏,等.当归芍药散治疗老年痴呆症的药理研究进展[J].安徽中医学院学报,1997,16(3):61-64.
[83]林志宏,朱丹妮,严永清,等.当归芍药散防治老年期痴呆的物质基础与作用机理研究Ⅰ[J].中国实验方剂学杂志,2002,8(l):18-21.
[84]舒斌,马世平.当归芍药散治疗老年痴呆研究进展[J].中国老年学杂志,2002,5(22):236-238.
[85]斋藤正已.老年痴呆的汉方治疗[J].现代东洋医学,1993,14:518-519.
[86]张新农.“黄连解毒汤”治疗脑血管意外后遗症及多发性梗塞性痴呆24例[J].实用中西医结合杂志,1992,2(5):146-148.
[87]荒木五朗.从临床角度看阿尔茨海默型老年痴呆[J].国外医学中医中药分册,1991,13:261-262.
[88]闫敬来.中医药治疗老年痴呆相关文献的用药规律研究[J].湖北中医学院,2007,18
[89]盛树力.老年性痴呆:从分子生物学到临床诊治[M].第一版:北京:科学技术文献出版社,1999:128-129.
[90]刘福根,高之旭,陈美娟,等.加兰他敏片治疗阿尔茨海默病的多中心、随机双盲评价[J].中国新药与临床杂志,2003,22(l):29-32.
[91]芮菁.中药治疗老年痴呆的研究概况[J].天津药学,2003,1(15):57-58.
[92]张旭静,曹奕丰,冯春红.川芎、当归对大鼠血栓形成的影响[J].中国临床药学杂志,2002,11(l):45.
[93]屈泽强,谢智光,王乃平,等.三七总皂苷抗衰老作用的实验研究[J].第二军医大学学报,2005,26(2):161-163.
[94]徐江平,杨雪梅.中草药活性成分防治阿尔采末病的研究进展[J].第一军医大学学报,2001,l:23.
[95]杨玲玲,苑辉卿,曾季平,等.培养神经细胞的氧自由基损伤及银杏叶提取物的治疗作用[J].中国老年学杂志,2005,1(25):130-133.
[96]He LN, He SB, Yang J. Protective effect of Tanshinones on primary cultured cortex neurons injury induced by ischemia[J].Chinese Pharmacological Bulletin,2001,17(2):214-216.
[97]李龙宣,茹立强.丹参酮对海马内注射淀粉样肽后大鼠学习记忆障碍的影响[J].中国老年学杂志,2003,23:294.
[98]刘艳红,赵胜利,石瑞如,等.黄芪、枸杞子对衰老大鼠SOD,LPO及其某些激素的影响[J].中药药理与临床,1996,2:20-22.
[99]刘孟渊,刘惠纯.益智中草药的研究概况[J].中国中西医结合杂志,2002,15(l):59.
[100]居贤水.艾灸延缓衰老的临床观察[J].上海针灸杂志,1995,14(3):99.
[101]于建春,彭永康,韩景献.双向电泳分析快速老化痴呆鼠脑蛋白质的异常表达及针刺的影响[J].针刺研究,2006,31(2) :73-76.
[102]孙长旺.针刺四神穴为主治疗老年性痴呆临床经验[J].天津中医, 1997, 14: 79-80
[103]梅静,刘春光,孙利.针灸治疗老年性痴呆76例[J].中国民间疗法,2003,11(12):13
[104]崔瑛,颜正华,侯士良等.熟地黄对动物学习记忆障碍及中枢氨基酸递质、受体的影响[J].中国中药杂志,2003, 28(9):862-866
[105]沈云辉,曹玉净,崔瑛等.熟地黄对拟痴呆模型小鼠记忆力的影响及机制研究[J].上海中医药杂志,2007, 41(4):67-68
[106]霍超,徐桂花.枸杞生理功效和活性成分的研究进展[J].中国食物与营养,2007, 11:50-53
[107]黄美燕,蔡宇,徐珍霞等.枸杞多糖对染铅小鼠学习记忆的影响[J].中国临床康复,2005,9(28):126-127
[108]陈以国,成泽东.论以脏补脏疗法与中药归经[J].辽宁中医杂志,2004,31(9):733-734
[109]林元藻,林向阳,万发达等.猪脑水解液的制备及其生物学活性研究[J].氨基酸和生物资源,1999,21(3):5-8
[110]陈奇.中药药理研究方法学[M].人民卫生出版社,1996,33.
[111]吴晓晴.动物实验基本操作技术手册[M].人民军医出版社,2008,82
[112]吴晓晴.动物实验基本操作技术手册[M].人民军医出版社,2008,77.
[113]Xinyu Yu.Neuroprotective effct of Alpinia oxyphylla Miq.fruits against flutamate-induced apoptosis in cortical neurons[J].Toxicology Letters,2003,144: 205-212.
[114]郭宗君,郭云良,许贞,等.药物诱发大鼠痴呆模型的初步研究[J].中国老年学杂志,1999,19(9):295-297.
[115]徐斌,陈俊抛,林焊,等.去松果体对大鼠学习记忆及海马结构星形胶质细胞的影响[J].中国行为医学科学,2000,9(3):188-190.
[116]徐路,任晓燕,陶尚敏,等.噪音致痫对大鼠学习行为的影响及其与脑内生长抑素含量的关系[J].中国行为医学科学,1997,6(4):249-250.
[117]李胜休,舒斯云,包新民,等.海仁藻酸损伤边缘区后对大鼠学习和记忆功能影响的研究[J].神经解剖学杂志,1996,12(3):37-41.
[118]甘思德.神经系统老化问题[J].生理科学进展,1991,22(3):240-243.
[119]裴媛,林庶茹,李德新.脑老化的中医药实验研究进展[J].中国老年学杂志,2005,6:740-742.
[120]Andersen MB,Sams-Dodd F. Transient cerebral ischemia inhibits juvenile recognition in the mongolian gerbil[J]. Pharmacol Biochem Behav. 1997,56:19-725.
[121]张亢奋.中医药防治老年性痴呆的研究现状与思路[J].安徽中医杂志,1999.21(1):3-6
[122]丛伟红,刘建勋.老年性痴呆动物模型研究进展.中国药理学通报[J],2003,19(5):497-501.
[123]张群业,崔行,郝建荣,等.Alzheimer病遗传学及转基因动物模型研究进展[J].中国老年学志,2002,27(22):320-323.
[124]徐秿本.哺乳动物亚急性衰老模型与抗衰老药理研究.第二届全国衰老科学研讨汇论文汇编,1985,1:24-25.
[125]宓鹤鸣,淫羊藿对D-gal亚急性中毒大鼠拟衰老生化改变[J].中国药理与临床,1990,6:18-20.
[126]刘天培,等.人参与三七皂甙对D-半乳糖所致小鼠虚损的研究.老年学杂志,1989,9:44-46.
[127]陈可冀,李春生.新编抗衰老中药学[M].第一版.北京:人民卫生出版社,1998:153-162.
[128]徐智.大鼠衰老模型的初步建立[J].第二军医大学学报,2003,25(4):312-314.
[129]罗红波,何明大.脑灵汤对模型大鼠学习记忆及海马内老年斑的影响[J].中国行为医学科学,2005,14(7):559-600.
[130]Kiyota Y,Miyamoto M,Nagaoka A. Relationship between brain damage and memory impairment in mouse exposed to transient forebrain ischemia[J]. Brain Res.1991,538:295-302.
[131]Nunn J,Hodges H.Cognitive deficits induced by global cerebral ischaemia:relationship to brain damage and reversal by transplants [J].Behav Brain Res.1994,65:1-31.
[132]余建,黄育文,陈忠.经过改良的评价大鼠空间记忆能力的交替电刺激Y型迷宫[J].浙江大学学报(医学版),2003,32(2):121-125.
[133]徐晓红.D-半乳糖致衰老小鼠记忆与海马突触形态学变化[J].卫生毒理学杂志,2001,15(4):206-209.
[134]王琦,任冬青,郭国祯,等.电磁脉冲照射对小鼠脑组织氧化还原状态的影响及姜黄素的治疗作用[J].中国康复理论与实践,2007,13(2):149-150.
[135]刘应柯,宫璀璀,刘尚岭.加味小柴胡汤对顺铂诱导大鼠肝BRL细胞过氧化损伤的保护作用[J].2006,12(19):17-18.
[136]Baojian X. Meredith H. 17β- estradiol inhibits excitatory amino acid -induced activity of neurons of the nucleus tractus solitarius [J] . Brain Res,2003,976 (1):41 -52.
[137] Xu H ,Gouras G K,Greenfield J P. Estrogen reduces neuronal genera2tion of Alzheimerβ- amyloid peptides[J]. Nat Med,1998,4: 447 -482.
[2]Katzman R,Kawas C.Risk faetor for Alzheimer’s disease[J].Neuroscience News,1998,l:27-34.
[3]杨任民.老年性痴呆—系列保健之二[J].临床中老年保健,2001,4(3):203-206
[4]www.bjzx.gov.cn/zxta/dpta/ng/021.htm
[5]闫芳,李淑然,刘津,等.老年期痴呆和老年抑郁症的流行病学调查[J].中华医学杂志,2002,82(15):1025 - 1028.
[6]汤荟冬.老年期痴呆的流行病学研究近况[J].中国实用内科学杂志,2002,22(6):365 - 366.
[7]Bachman,D.L.,P.A.Wolf,etal. Incidence of dementia and probable Alzheimer’s disease in a general population the Framingham Study[J].Neurology,1993,43(3 Pt 1):515-9.
[8]Rocca,W.A.,A.Hofman,etal. Frequency and distribution of Alzheimer’s disease in Europe:a collaborative study of 1980-1990 Prevalence findings[J]. The EURODEM-Prevalence Research Group.Ann Neurol,1991,30(3):381-90.
[9]许二赫,贾建平.Alzheimer病的分子遗传学进展[J].中风与神经疾病杂志,2002,19(1):59-61.
[10]贾建平,张津,徐敏等.载脂蛋白E基因多态性与散发性阿尔茨海默病的关系[J].中华老年医学杂志,2002,21(4):248-250.
[11]杨小清.老年性痴呆症的流行病学特征及预防[J].职业与健康,2008,24(13):1317-1318.
[12]Akiyama H,Barger S,Barnum S, etal.Inflammation and Alzheimer’s disease[J]. Neurobiology of Aging,2000,21(3):383-421.
[13]Sastre M,Klockgether T,Heneka MT. Contribution of inflammatory Processes to Alzheimer’s disease: molecular mechanisms[J].International Journal of Development Neuroscience,2006,24(2-3):167-176.
[14]Ladurner G,Hiff LD,Lechner H.Clinical factors associated with dementia in ischaemic stroke [J]. Journal of neurology,neurosurgery and psychiatry,1982,45(2):97-101.
[15]AZAD NA,AL BUGAMI M ,LOY-ENGLISH I. Gender Differences in Dementia Risk Factors[J]. Gend Med (S1550 - 8579 ),2007,4(2) :120-129.
[16]Sawada H,Ibi M,Kihara T, etal.Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons [J].The FASEBJ Journal,2000,14(9):1202-1214.
[17]王荫华.阿尔茨海默病的危险因素[J].中华神经科杂志,2003,36(6):477-478.
[18]汤哲,孟琛.瑞士老年医学与老年痴呆研究现状[J].中华老年医学杂志,1999,18(3):191.
[19]Hardy J, Selkoe DJ.The amyloid hypothesis of Alzheimer’s disease: Progress and Problems on the road to therapeutics [J].Science,2002,297(5580):353-356.
[20] Shirotain K, Tsubuki S, IwataN et al. Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapide and efficiently among thiorphan and phosphoramidon sensitive endopeptidases[J].Biol Chem,2001.276 (24):21895-21901.
[21]PiccardiM, CongiuD, Squassina A et al. Alzheimer’s disease: case-control association study of 1polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample1 [J].Am JMed GenetB Neuropsychiatr Genet, 2007, 144 (7):895-899.
[22]Coyle JT,Price DL,DeLong MR. Alzheimer’s disease: a disorder of cortical cholinergic innervation[J].Science,1983,219(4589):1184-1190.
[23] Matsui T, Ingelsson M, Fukumoto H et al. Expression of APP pathway mRNAs and proteins in Alzheimer’s disease1[J].Brain Res, 2007, 1161: 116-123.
[24]Mann D,PickeringcBrowns,Takerchi A,Iwatsubo T. Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer’s disease[J].American Journal of Pathology,2001,158(6):2165.
[25]Mariani E, SeripaD, Ingegni T et al1 Interaction of CTSD and A2M polymorphisms in the risk forAlzheimer’s disease1[J].Neurol Sci,2006,247 (2):187-191.
[26]Lee MS,Kao SC,Lemere CA,etal.APP processing is regulated by cytoplasmic phosphorylation [J]. Cell Biol,2003,163(1):83-95.
[27]Selkoe DJ. Alzheimer’s disease is a synaptic failure[J].Science,2002,298(5594):781-791.
[28] Liu Y, Liu F, Iqbal K et al. Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease[J]. FEB SL ett,2008, 582(2): 359-364.
[29]McGeer PL, McGeer EG..Autotoxicity and Alzheimer disease[J].Arch Neurol,200,57 (6):789 -790.
[30]Aisen PS. The inflammatory hypothesis of Alzheimer disease: dead or alive? [J].Alzheimer Dis Assoc Disord,2008,22(1):4-5.
[31]吴正治,唐春艳,卢汉平.天泰Ⅱ号对实验性老年痴呆益智作用及机理探讨[J].中药新药与临床药理,1999,10(1):32.
[32]Leigh PN, etal. New aspects of the pathology of neurodegrenerative disorders as revealed by ubiquitin antiboeies[J]. Acta NeuroPathol,1989,79:61-72.
[33]丁新生.老年性痴呆的病理、发病机制及其诊断研究[J].中国临床康复,2004,8(19):3174-3176.
[34]Ogomoto K,etal.Re-examination of granulovacuolar degeneration[J].Acta Neuropatho l,1991,12:821-9256.
[35]Terry RD,etal.Some morphometric aspects of the brain in senile dementia of the Alzheimer type[J]. Ann Neurol,1991,10:182-194.
[36]官志忠阿尔茨海默病的病理学及生物膜结构与受体改变机制[J].中华病理学杂志,2003,32(1):425-426.
[37]SpencerCM,Noble S,etal.A reviews of its use in Alzheimer’s disease[J].Drugs-Aging,1998, 13(5):391-411.
[39]Giacobini E. Long-term stabilizing effect of cholinesterase inhibitors in the therapy of Alzheimer’s disease [J].Journal of Neural Transmission Supplemen,2002,(62):181-187.
[38]Rogers SL, Doody R.E2020 produced both clinical global and cognitive test Improvement in patient with mild to moderately sever Alzheimer’s disease: results of a 30-weeks phaseⅢtrial. Neurology,1996,46:217.
[40]钟志耕,梁可珍.石杉碱甲治疗血管性痴29例临床观察[J].海南医学院学报,2004(10) :25.
[41]Frederick B, Satlin A, Wald LL, etal.Brain proton magnetic resonance spectroseopy in Alzheimer’s disease:changes after treatment with xanomeline[J].American Journal of Geriatric Psychiatry,2002,10(l):81-88.
[42]Ishige K, Schubert D, Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms[J].Free Radical Biology and Medicine,2001,30(4):433-466.
[43]Tuszynski MH. Intraparenchymal NGF infusions rescue degenerating cholinergic neurons[J].Cell Transplant,2000,9(5):629-636.
[44]肖飞,罗焕敏.靶向β-和γ-分泌酶治疗阿尔茨海默病的研究进展[J].国外医学,药学分册,2002,29(5):272-278.
[45]Wong GT, Manfra D, Poulet FM, etal. Chronic treatment with the gamma-secretase inhibitorLY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation[J].Journal of Biological Chemistry,2004,279(13):12876-12882.
[46]Andersona JJ, Holtza G, Baskin PP, etal. Reductions in beta-amyloid concentrations in vivo by the gamma-secretas inhibitors BMS-289948andBMS-299897[J].Biochemical Pharmacolo- g,2005,69:689-698.
[47] Grundman M,Delaney P. Antioxidant strategic for Alzheimer’s disease[J].AM.J.Med,2000, 109(7):57-585.
[48] Bard F, Cannon C, Barbour R, etal. Peripherally administered antibodies against amyloid beta peptide enter the central nervous system and reduce Pathology in a mouse model of Alzheimer disease[J].Nature Medicine,2000,6(8):916-919.
[49]胡章,马润娣.药物防治阿尔茨默病研究[J].实用老年医学,2000,14(5):262-264.
[50]Breitner J C, Gau A ,Welsh K A. Inverse association of anti-inflammatory treatments and Alzheimer’s disease:initial results of a cot win control study[J].Neurology,1994,44 (2 ):227.
[51]McGeer PL, McGeer EG.NSAIDs and Alzheimer disease: epidemiological,animal model and clinical studies[J].Neurobiology of Aging,2007,28(5):639-647.
[52]HendersonVW,Paganini2Hill A,Emanuel C K. Estrogen replacement therapy in older women: comparisons between Alzheimer’s disease cases and non-demented control subjects[J].Arch Neurol,1994,51(9) :816.
[53]Baker LD, Sambamurti K, Craft S, et al. 17 beta-estuarial reduces plasma A beta 40 for HRT naive postmenopausal women with Alzheimer disease: a preliminary study[J].Am J Geriatr Psychiatry,2003,11(2):239-244.
[54]高之旭,徐一峰.阿尔采夫病的药物治疗评价[J].中国新药与临床杂志,2000,l9(l):46-48.
[55]卜海涛.中华医学会第三届全国老年期痴呆和抑郁症学术会议纪要[J].中华神经科杂,2004,37(2):102-105.
[56]张映梅.老年痴呆症虚实论治[J].云南中医中药杂志, 2000,21: 36-37.
[57]张新风.补肾填精汤治疗老年性痴呆30例临床观察[J].江西中医药,2005,36(12):23.
[58]腾晶.补肾化痰祛瘀法治疗老年期痴呆机理探讨[J].河南中医,2003,23(7):5-6.
[59]欧阳真理.老年痴呆的病因病机探讨与治疗[J].中华实用中西医杂志,2005,18(13):212.
[60]赵文研,陈荣.从脾论治老年性痴呆症[J].中医药学刊,2005, 23(9):1666.
[61]朱振铎.疏肝解郁、滋肾养心法治疗老年性痴呆34例临床研究[J].山东中医药大学学报,1998,22(5):346-349.
[62]郑丽,翟李娟.辨证分型治疗老年痴呆症30例疗效观察[J].河南中医学院学报,2004,19(4):113.
[63]魏翠柏,田金洲,贾建平.老年痴呆中医病因病机理论的认识与思考[J].中华中医药杂志,2005,20(8):496-497.
[64]董洪涛,金渊光.老年性痴呆痰蒙神窍病因病机探析[J].中国传统医学杂志,2002,20(6):755-756.
[65]宋颖民.痰瘀同治法治疗老年性痴呆体会[J].河北中医,1998,20(4):218-311.
[66]孙明杰,于友华.清热解毒中药防治老年性痴呆症之理论探讨[J].中国中医基础医学杂志,2003, 9(2): 17
[67]张晋,刘荣,董健.名老中医治疗老年性痴呆经验评述[J].中医药信息, 2001, 18(3): 1-2
[68]郑现堂.益精活血通窍法治疗老年性痴呆[J].中原医刊, 2001,28(9): 60-61
[69]李鹏英.心、肾、肝在老年性痴呆发病中的作用[J].长春中医学院学报, 2000, 16(1): 7-8
[70]浦斌红,何建成.浅谈老年性痴呆模型的发病机理及其中医药治疗[J].光明中医,2002, 17(98): 18-19
[71]周念兴.老年性痴呆从胆论治的临床探讨[J].北京中医,1998, (1): 14
[72]魏录翠,胡国恒,张强等.从肺论治老年性痴呆理论探讨[J].江西中医学院学报,2008, 20(5): 16-17
[73]李雅根.浅析从痰瘀互结论治老年性痴呆[J].江西中医药,2002, 33(2): 17
[74]张觉人.呆从痰治[J].上海中医药杂志, 1995, 29(3): 20
[75]赵伟康.调心方对杏仁核注Aβ大鼠记忆行为和胆碱能系统作用的研究[J].现代康复,2001,5(5):48-50.
[76]赵伟康.调理心肾中药对大鼠痴呆模型的胆碱能和肾上腺素能神经系统的影响[J].中国中西医结合杂志,1993,13(特集):20-23.
[77]林长兴.调补心肾改善老年性痴呆智力的临床研究[J].上海中医药杂志,1995,(9):8-10.
[78]原敬二朗.痴呆症和东洋医学[J].日本医事新报,1991,46:3514-3516.
[79]许哲,邵金莺,刘干中.左归丸的一些药理作用[J].中药药理与临床,1990,6(4):6-8.
[80]王昌俊.益智灵为主治疗老年痴呆[J].中国医药学报,1993,8:33-34.
[81]王昌俊.益智灵的益智健脑作用的研究[J].中成药,1993,15(6):28-29.
[82]杨军,魏守建,高丹屏,等.当归芍药散治疗老年痴呆症的药理研究进展[J].安徽中医学院学报,1997,16(3):61-64.
[83]林志宏,朱丹妮,严永清,等.当归芍药散防治老年期痴呆的物质基础与作用机理研究Ⅰ[J].中国实验方剂学杂志,2002,8(l):18-21.
[84]舒斌,马世平.当归芍药散治疗老年痴呆研究进展[J].中国老年学杂志,2002,5(22):236-238.
[85]斋藤正已.老年痴呆的汉方治疗[J].现代东洋医学,1993,14:518-519.
[86]张新农.“黄连解毒汤”治疗脑血管意外后遗症及多发性梗塞性痴呆24例[J].实用中西医结合杂志,1992,2(5):146-148.
[87]荒木五朗.从临床角度看阿尔茨海默型老年痴呆[J].国外医学中医中药分册,1991,13:261-262.
[88]闫敬来.中医药治疗老年痴呆相关文献的用药规律研究[J].湖北中医学院,2007,18
[89]盛树力.老年性痴呆:从分子生物学到临床诊治[M].第一版:北京:科学技术文献出版社,1999:128-129.
[90]刘福根,高之旭,陈美娟,等.加兰他敏片治疗阿尔茨海默病的多中心、随机双盲评价[J].中国新药与临床杂志,2003,22(l):29-32.
[91]芮菁.中药治疗老年痴呆的研究概况[J].天津药学,2003,1(15):57-58.
[92]张旭静,曹奕丰,冯春红.川芎、当归对大鼠血栓形成的影响[J].中国临床药学杂志,2002,11(l):45.
[93]屈泽强,谢智光,王乃平,等.三七总皂苷抗衰老作用的实验研究[J].第二军医大学学报,2005,26(2):161-163.
[94]徐江平,杨雪梅.中草药活性成分防治阿尔采末病的研究进展[J].第一军医大学学报,2001,l:23.
[95]杨玲玲,苑辉卿,曾季平,等.培养神经细胞的氧自由基损伤及银杏叶提取物的治疗作用[J].中国老年学杂志,2005,1(25):130-133.
[96]He LN, He SB, Yang J. Protective effect of Tanshinones on primary cultured cortex neurons injury induced by ischemia[J].Chinese Pharmacological Bulletin,2001,17(2):214-216.
[97]李龙宣,茹立强.丹参酮对海马内注射淀粉样肽后大鼠学习记忆障碍的影响[J].中国老年学杂志,2003,23:294.
[98]刘艳红,赵胜利,石瑞如,等.黄芪、枸杞子对衰老大鼠SOD,LPO及其某些激素的影响[J].中药药理与临床,1996,2:20-22.
[99]刘孟渊,刘惠纯.益智中草药的研究概况[J].中国中西医结合杂志,2002,15(l):59.
[100]居贤水.艾灸延缓衰老的临床观察[J].上海针灸杂志,1995,14(3):99.
[101]于建春,彭永康,韩景献.双向电泳分析快速老化痴呆鼠脑蛋白质的异常表达及针刺的影响[J].针刺研究,2006,31(2) :73-76.
[102]孙长旺.针刺四神穴为主治疗老年性痴呆临床经验[J].天津中医, 1997, 14: 79-80
[103]梅静,刘春光,孙利.针灸治疗老年性痴呆76例[J].中国民间疗法,2003,11(12):13
[104]崔瑛,颜正华,侯士良等.熟地黄对动物学习记忆障碍及中枢氨基酸递质、受体的影响[J].中国中药杂志,2003, 28(9):862-866
[105]沈云辉,曹玉净,崔瑛等.熟地黄对拟痴呆模型小鼠记忆力的影响及机制研究[J].上海中医药杂志,2007, 41(4):67-68
[106]霍超,徐桂花.枸杞生理功效和活性成分的研究进展[J].中国食物与营养,2007, 11:50-53
[107]黄美燕,蔡宇,徐珍霞等.枸杞多糖对染铅小鼠学习记忆的影响[J].中国临床康复,2005,9(28):126-127
[108]陈以国,成泽东.论以脏补脏疗法与中药归经[J].辽宁中医杂志,2004,31(9):733-734
[109]林元藻,林向阳,万发达等.猪脑水解液的制备及其生物学活性研究[J].氨基酸和生物资源,1999,21(3):5-8
[110]陈奇.中药药理研究方法学[M].人民卫生出版社,1996,33.
[111]吴晓晴.动物实验基本操作技术手册[M].人民军医出版社,2008,82
[112]吴晓晴.动物实验基本操作技术手册[M].人民军医出版社,2008,77.
[113]Xinyu Yu.Neuroprotective effct of Alpinia oxyphylla Miq.fruits against flutamate-induced apoptosis in cortical neurons[J].Toxicology Letters,2003,144: 205-212.
[114]郭宗君,郭云良,许贞,等.药物诱发大鼠痴呆模型的初步研究[J].中国老年学杂志,1999,19(9):295-297.
[115]徐斌,陈俊抛,林焊,等.去松果体对大鼠学习记忆及海马结构星形胶质细胞的影响[J].中国行为医学科学,2000,9(3):188-190.
[116]徐路,任晓燕,陶尚敏,等.噪音致痫对大鼠学习行为的影响及其与脑内生长抑素含量的关系[J].中国行为医学科学,1997,6(4):249-250.
[117]李胜休,舒斯云,包新民,等.海仁藻酸损伤边缘区后对大鼠学习和记忆功能影响的研究[J].神经解剖学杂志,1996,12(3):37-41.
[118]甘思德.神经系统老化问题[J].生理科学进展,1991,22(3):240-243.
[119]裴媛,林庶茹,李德新.脑老化的中医药实验研究进展[J].中国老年学杂志,2005,6:740-742.
[120]Andersen MB,Sams-Dodd F. Transient cerebral ischemia inhibits juvenile recognition in the mongolian gerbil[J]. Pharmacol Biochem Behav. 1997,56:19-725.
[121]张亢奋.中医药防治老年性痴呆的研究现状与思路[J].安徽中医杂志,1999.21(1):3-6
[122]丛伟红,刘建勋.老年性痴呆动物模型研究进展.中国药理学通报[J],2003,19(5):497-501.
[123]张群业,崔行,郝建荣,等.Alzheimer病遗传学及转基因动物模型研究进展[J].中国老年学志,2002,27(22):320-323.
[124]徐秿本.哺乳动物亚急性衰老模型与抗衰老药理研究.第二届全国衰老科学研讨汇论文汇编,1985,1:24-25.
[125]宓鹤鸣,淫羊藿对D-gal亚急性中毒大鼠拟衰老生化改变[J].中国药理与临床,1990,6:18-20.
[126]刘天培,等.人参与三七皂甙对D-半乳糖所致小鼠虚损的研究.老年学杂志,1989,9:44-46.
[127]陈可冀,李春生.新编抗衰老中药学[M].第一版.北京:人民卫生出版社,1998:153-162.
[128]徐智.大鼠衰老模型的初步建立[J].第二军医大学学报,2003,25(4):312-314.
[129]罗红波,何明大.脑灵汤对模型大鼠学习记忆及海马内老年斑的影响[J].中国行为医学科学,2005,14(7):559-600.
[130]Kiyota Y,Miyamoto M,Nagaoka A. Relationship between brain damage and memory impairment in mouse exposed to transient forebrain ischemia[J]. Brain Res.1991,538:295-302.
[131]Nunn J,Hodges H.Cognitive deficits induced by global cerebral ischaemia:relationship to brain damage and reversal by transplants [J].Behav Brain Res.1994,65:1-31.
[132]余建,黄育文,陈忠.经过改良的评价大鼠空间记忆能力的交替电刺激Y型迷宫[J].浙江大学学报(医学版),2003,32(2):121-125.
[133]徐晓红.D-半乳糖致衰老小鼠记忆与海马突触形态学变化[J].卫生毒理学杂志,2001,15(4):206-209.
[134]王琦,任冬青,郭国祯,等.电磁脉冲照射对小鼠脑组织氧化还原状态的影响及姜黄素的治疗作用[J].中国康复理论与实践,2007,13(2):149-150.
[135]刘应柯,宫璀璀,刘尚岭.加味小柴胡汤对顺铂诱导大鼠肝BRL细胞过氧化损伤的保护作用[J].2006,12(19):17-18.
[136]Baojian X. Meredith H. 17β- estradiol inhibits excitatory amino acid -induced activity of neurons of the nucleus tractus solitarius [J] . Brain Res,2003,976 (1):41 -52.
[137] Xu H ,Gouras G K,Greenfield J P. Estrogen reduces neuronal genera2tion of Alzheimerβ- amyloid peptides[J]. Nat Med,1998,4: 447 -482.